| Patent | Date |
|---|
A Process For The Preparation Of Venetoclax And Its Polymorphs Thereof
App 20220259204 - SIRIGIREDDY; Balakrishna Reddy ; et al. | 2022-08-18 |
Process for the preparation of ribociclib succinate and its novel crystalline forms thereof
Grant 11,414,421 - Thiriveedhi , et al. August 16, 2 | 2022-08-16 |
Process For The Preparation Of High Pure Eribulin And Its Mesylate Salt
App 20220089607 - DIVYA; Prabhakar ; et al. | 2022-03-24 |
Improved Process For The Preparation Of Tipiracil Hydrochloride And Intermediates Thereof
App 20220056016 - SAKKANI; Srinivasulu ; et al. | 2022-02-24 |
Process for the preparation of pomalidomide and its purification
Grant 11,111,228 - Konakanchi , et al. September 7, 2 | 2021-09-07 |
Intermediates for the preparation of eribulin thereof
Grant 11,008,296 - Vipparla , et al. May 18, 2 | 2021-05-18 |
An Improved Process For The Preparation Of Ribociclib Succinate And Its Novel Crystalline Forms Thereof
App 20210122754 - THIRIVEEDHI; Arunkumar ; et al. | 2021-04-29 |
Process for the preparation of amorphous idelalisib
Grant 10,870,650 - Kompella , et al. December 22, 2 | 2020-12-22 |
Process for the preparation of dasatinib polymorph
Grant 10,800,771 - Konakanchi , et al. October 13, 2 | 2020-10-13 |
Intermediates For The Preparation Of Eribulin Thereof
App 20200299248 - VIPPARLA; Bulli Babi ; et al. | 2020-09-24 |
Modified process for the preparation of Ceritinib and amorphous form of Ceritinib
Grant 10,604,505 - Konakanchi , et al. | 2020-03-31 |
Process For The Preparation Of Amorphous Idelalisib
App 20200095249 - KOMPELLA; Amala ; et al. | 2020-03-26 |
An Improved Process For The Preparation Of Dasatinib Polymorph
App 20190292177 - KONAKANCHI; Durga Prasad ; et al. | 2019-09-26 |
Process For The Preparation Of Pomalidomide And Its Purification
App 20190233389 - Konakanchi; Durga Prasad ; et al. | 2019-08-01 |
Modified Process For The Preparation Of Ceritinib And Amorphous Form Of Ceritinib
App 20190047983 - Konakanchi; Durga Prasad ; et al. | 2019-02-14 |
7-(morpholinyl)-2-(N-piperazinyl) methyl thieno [2, 3-C] pyridine derivatives as anticancer drugs
Grant 10,106,554 - Konakanchi , et al. October 23, 2 | 2018-10-23 |
Anhydrous lenalidomide form-I
Grant 10,040,778 - Konakanchi , et al. August 7, 2 | 2018-08-07 |
7-(morpholinyl)-2-(n-piperazinyl) Methyl Thieno [2, 3-c] Pyridine Derivatives As Anticancer Drugs
App 20170320891 - KONAKANCHI; Durga Prasad ; et al. | 2017-11-09 |
Anhydrous Lenalidomide Form-i
App 20150353525 - Konakanchi; Durga Prasad ; et al. | 2015-12-10 |
Anhydrous lenalidomide form-I
Grant 9,108,945 - Konakanchi , et al. August 18, 2 | 2015-08-18 |
Anhydrous lenalidomide form-I
Grant 8,877,932 - Konakanchi , et al. November 4, 2 | 2014-11-04 |
Anhydrous Lenalidomide Form-i
App 20140121245 - Konakanchi; Durga Prasad ; et al. | 2014-05-01 |
Anhydrous Lenalidomide Form-i
App 20130059889 - Konakanchi; Durga Prasad ; et al. | 2013-03-07 |
Pyrazolo [3,4-D] pyrimidine derivatives as anti-cancer agents
Grant 8,349,847 - Konakanchi , et al. January 8, 2 | 2013-01-08 |
Novel 4-(tetrazol-5-yl)-quinazoline Derivatives As Anti Cancer Agent
App 20120172380 - Konakanchi; Durga prasad ; et al. | 2012-07-05 |
4-(tetrazol-5-yl)-quinazoline derivatives as anti-cancer agent
Grant 8,080,558 - Konakanchi , et al. December 20, 2 | 2011-12-20 |
Novel Pyrazolo [3, 4 -d] Pyrimidine Derivatives As Anti-cancer Agents
App 20100298351 - Konakanchi; Durga Prasad ; et al. | 2010-11-25 |
| 